Swiss Life Asset Management Ltd
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1637689
Zurich, V8
Position in VRTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$45,507,422
+$8,634,829 QoQ
Shares Held
91,614
+10.9% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#180
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $122,705,584 across 67 Biotechnology names. VRTX ranks #1 (37.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
91,614 | $45,507,422 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,220 | $17,596,298 | |
| 3 | INCY |
Incyte Corp
|
104,901 | $11,891,577 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,327 | $8,828,306 | |
| 5 | RPRX |
Royalty Pharma plc
|
136,283 | $7,641,386 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
17,736 | $3,321,598 | |
| 7 | INSM |
INSMED Inc
|
27,552 | $2,937,594 | |
| 8 | MRNA |
Moderna, Inc.
|
25,088 | $1,756,912 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,507,422 | 91,614 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $36,872,593 | 82,574 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $33,103,440 | 73,018 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $25,043,419 | 63,945 | Shares | Defined | 2025-12-02 | |
| 2025-06-30 | $25,777,079 | 57,900 | Shares | Defined | 2025-12-02 | |
| 2025-03-31 | $14,352,610 | 29,604 | Shares | Defined | 2025-12-02 | |
| 2024-12-31 | $10,335,697 | 25,666 | Shares | Sole | 2025-12-09 | |
| 2024-09-30 | $12,795,745 | 27,513 | Shares | Defined | 2025-12-09 | |
| 2024-06-30 | $19,737,329 | 42,109 | Shares | Sole | 2025-12-09 | |
| 2024-03-31 | $8,724,704 | 20,872 | Shares | Sole | 2025-12-09 | |
| 2023-12-31 | $17,276,141 | 42,459 | Shares | Sole | 2025-12-09 | |
| 2023-09-30 | $12,896,632 | 37,087 | Shares | Sole | 2025-12-09 | |
| 2023-06-30 | $13,631,233 | 38,735 | Shares | Sole | 2025-12-09 | |
| 2023-03-31 | $15,500,813 | 49,198 | Shares | Sole | 2025-12-09 | |
| 2022-12-31 | $12,610,155 | 43,667 | Shares | Sole | 2025-12-09 | |
| 2022-09-30 | $11,234,440 | 38,801 | Shares | Sole | 2025-12-09 | |
| 2022-06-30 | $13,604,538 | 48,279 | Shares | Sole | 2025-12-09 | |
| 2022-03-31 | $3,971,701 | 15,219 | Shares | Sole | 2025-12-09 | |
| 2021-12-31 | $3,318,375 | 15,111 | Shares | Sole | 2025-12-29 | |
| 2021-09-30 | $9,243,452 | 50,959 | Shares | Sole | 2025-12-29 | |
| 2021-06-30 | $12,823,264 | 63,598 | Shares | Defined | 2025-12-29 | |
| 2021-03-31 | $9,152,594 | 42,592 | Shares | Defined | 2025-12-29 | |
| 2020-12-31 | $9,276,344 | 39,250 | Shares | Sole | 2025-12-29 | |
| 2020-09-30 | $15,543,766 | 57,121 | Shares | Defined | 2025-12-29 | |
| 2020-06-30 | $14,729,747 | 50,738 | Shares | Sole | 2025-12-29 | |
| 2020-03-31 | $11,145,101 | 46,838 | Shares | Defined | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||